BIOMAT Database Logo BIOMAT Database Logo

Inhibition of HIV-1 replication by triple-helix-forming phosphorothioate oligonucleotides targeted to the polypurine tract. 1997

S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Department of Industrial Chemistry, Chiba Institute of Technology, Japan.

We show the effects of triple-helix formation by assays of primer extension inhibition in vitro using two systems (two-strand-system (FTFOs) or three-strand-system (TFOs) targeted to the polypurine tract (PPT) of HIV-1. The FTFOs were more effective than the TFOs. We found that the FTFOs containing phosphorothioate groups at the 3'- and 5'-ends, or inside the hairpin loop, exhibited higher inhibitory effects on cDNA synthesis and greater exonuclease resistance than the unmodified FTFOs and TFOs. The abilities of the FTFOs containing phosphorothioate groups at the antisense sequence sites to inhibit HIV-1 replications were examined. The FTFOs containing phosphorothioate groups at the antisense sequence sites inhibit the replication of HIV-1 more efficiently than the antisense oligonucleotides, indicating sequence-specific inhibition of HIV-1 replication.

UI MeSH Term Description Entries
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D013873 Thionucleotides Nucleotides in which the base moiety is substituted with one or more sulfur atoms.
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human

Related Publications

S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Anti-HIV-1 activity by a triple-helix forming oligonucleotides targeted to polypurine tract on viral RNA.
January 2000, Nucleosides, nucleotides & nucleic acids,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Inhibition of HIV-1 replication by foldback triple-helix forming oligonucleotides.
January 1997, Nucleic acids symposium series,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Inhibition of replication initiation by triple helix-forming oligonucleotides.
December 1995, Biochemical and biophysical research communications,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides.
January 1993, Biochimie,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Inhibition of HIV-1 integration by mono- & bi-functionalized triple helix forming oligonucleotides.
January 1999, Nucleosides & nucleotides,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Inhibition of HIV-1 replication by a two-strand system (FTFOs) targeted to the polypurine tract.
July 1999, FEBS letters,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Inhibition of HIV-1 reverse transcription by triple-helix forming oligonucleotides with viral RNA.
April 1995, Nucleic acids research,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Targeted gene knockout mediated by triple helix forming oligonucleotides.
October 1998, Nature genetics,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Specific inhibition of transcription by triple helix-forming oligonucleotides.
January 1992, Proceedings of the National Academy of Sciences of the United States of America,
S Tsukahara, and J Suzuki, and T Hiratou, and K Takai, and Y Koyanagi, and N Yamamoto, and H Takaku
Gene targeting by triple helix-forming oligonucleotides.
December 2003, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!